
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Raajit K. Rampal discloses the following relationships and financial interests:
-
AbbVie
Professional Services and Activities -
Blueprint Medicines
Professional Services and Activities -
Bristol-Myers Squibb
Professional Services and Activities -
CTI BioPharma Corp.
Professional Services and Activities -
Chinese Medical Association
Professional Services and Activities -
Cogent Biosciences, Inc.
Professional Services and Activities -
Cowen and Company, LLC
Professional Services and Activities -
Galecto Biotech ApS
Professional Services and Activities -
Gilead Sciences, Inc.
Professional Services and Activities -
GlaxoSmithKline
Professional Services and Activities -
Greg Colman Law PC
Professional Services and Activities
-
Incyte
Professional Services and Activities -
Kartos Therapeutics, Inc.
Professional Services and Activities -
Karyopharm
Professional Services and Activities -
MPN Research Foundation
Professional Services and Activities -
MorphoSys AG
Professional Services and Activities -
Novartis
Professional Services and Activities -
Protagonist Therapeutics, Inc.
Professional Services and Activities -
Sierra Oncology, Inc
Professional Services and Activities -
Stemline Therapeutics, Inc.
Professional Services and Activities -
Sumitomo Pharma
Professional Services and Activities -
Zentalis Pharmaceuticals
Professional Services and Activities
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures